Aberdeen Group plc Grows Holdings in Agilent Technologies, Inc. $A

Key Points

• Aberdeen Group plc increased its holdings in Agilent Technologies by 10% in the second quarter, now owning approximately 0.10% of the company valued at $34.5 million.
• Agilent Technologies reported earnings of $1.37 per share, meeting expectations, with a revenue of $1.74 billion for the quarter, reflecting a 10.1% year-over-year increase.
• The company declared a quarterly dividend of $0.248 to be paid on October 22, with a current annualized yield of 0.7%.

Aberdeen Group plc raised its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 10.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 292,661 shares of the medical research company's stock after purchasing an additional 26,625 shares during the period. Aberdeen Group plc owned about 0.10% of Agilent Technologies worth $34,537,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Stone House Investment Management LLC bought a new position in Agilent Technologies during the 1st quarter valued at $30,000. Opal Wealth Advisors LLC acquired a new stake in shares of Agilent Technologies in the 1st quarter valued at about $31,000. Ransom Advisory Ltd bought a new position in shares of Agilent Technologies during the first quarter worth about $32,000. Central Pacific Bank Trust Division acquired a new position in Agilent Technologies in the second quarter worth about $33,000. Finally, Zions Bancorporation National Association UT bought a new stake in Agilent Technologies in the first quarter valued at about $38,000.

Agilent Technologies Stock Performance

A opened at $136.62 on Monday. The business has a 50 day moving average price of $125.04 and a two-hundred day moving average price of $117.02. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.25 and a quick ratio of 1.71. The company has a market capitalization of $38.73 billion, a price-to-earnings ratio of 32.07, a price-to-earnings-growth ratio of 4.46 and a beta of 1.26. Agilent Technologies, Inc. has a 1-year low of $96.43 and a 1-year high of $153.84.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, August 27th. The medical research company reported $1.37 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.37. Agilent Technologies had a return on equity of 25.51% and a net margin of 17.97%.The company had revenue of $1.74 billion for the quarter, compared to analysts' expectations of $1.67 billion. During the same period last year, the firm earned $1.32 EPS. The firm's revenue for the quarter was up 10.1% on a year-over-year basis. Agilent Technologies has set its FY 2025 guidance at 5.560-5.590 EPS. Q4 2025 guidance at 1.570-1.600 EPS. Research analysts predict that Agilent Technologies, Inc. will post 5.58 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, October 22nd. Shareholders of record on Tuesday, September 30th will be issued a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 30th. Agilent Technologies's dividend payout ratio is presently 23.24%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently weighed in on A shares. Evercore ISI boosted their price objective on shares of Agilent Technologies from $128.00 to $140.00 and gave the company an "in-line" rating in a research report on Tuesday, October 7th. Rothschild Redb raised shares of Agilent Technologies to a "strong-buy" rating in a report on Wednesday, October 8th. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $140.00 to $150.00 and gave the stock an "overweight" rating in a research report on Monday, September 15th. Barclays lifted their price objective on shares of Agilent Technologies from $125.00 to $150.00 and gave the company an "equal weight" rating in a research report on Thursday, October 2nd. Finally, Weiss Ratings restated a "hold (c)" rating on shares of Agilent Technologies in a research report on Wednesday, October 8th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $148.69.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies, Inc. (NYSE:A - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.